Inflammation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
127
|
|
0.600 |
None |
1.000 |
15 |
|
2001 |
2016 |
Hyperalgesia, Thermal
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.330 |
None |
1.000 |
11 |
|
1995 |
2019 |
Hyperalgesia, Primary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.300 |
None |
1.000 |
11 |
|
1995 |
2016 |
Hyperalgesia, Secondary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.300 |
None |
1.000 |
11 |
|
1995 |
2016 |
Mechanical Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.400 |
None |
1.000 |
11 |
|
1995 |
2019 |
Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
84
|
|
0.300 |
None |
1.000 |
11 |
|
1995 |
2016 |
Tactile Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.320 |
None |
1.000 |
11 |
|
1995 |
2019 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.600 |
None |
1.000 |
11 |
|
1995 |
2020 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
89
|
|
0.300 |
None |
1.000 |
10 |
|
2000 |
2014 |
Arthritis, Experimental
|
disease |
Musculoskeletal Diseases
|
Experimental Model of Disease
|
40
|
|
0.300 |
None |
1.000 |
9 |
|
1995 |
2012 |
Arthritis, Adjuvant-Induced
|
disease |
Musculoskeletal Diseases
|
Experimental Model of Disease
|
40
|
|
0.300 |
None |
1.000 |
9 |
|
1995 |
2012 |
Arthritis, Collagen-Induced
|
disease |
Musculoskeletal Diseases
|
Experimental Model of Disease
|
40
|
|
0.300 |
None |
1.000 |
9 |
|
1995 |
2012 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.500 |
None |
1.000 |
6 |
|
2002 |
2014 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.300 |
None |
1.000 |
6 |
|
2002 |
2013 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
|
0.300 |
None |
1.000 |
6 |
|
1995 |
2012 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.300 |
None |
1.000 |
6 |
|
2002 |
2013 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
|
0.300 |
None |
1.000 |
6 |
|
1995 |
2012 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
38
|
0.500 |
None |
1.000 |
6 |
|
1995 |
2019 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
404
|
|
0.300 |
None |
1.000 |
6 |
|
1995 |
2012 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
|
0.310 |
None |
1.000 |
6 |
|
1995 |
2012 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
1
|
0.350 |
None |
0.818 |
6 |
|
1995 |
2019 |
Heart Decompensation
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
110
|
|
0.300 |
None |
1.000 |
5 |
|
2004 |
2018 |
Myocardial Failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
110
|
|
0.300 |
None |
1.000 |
5 |
|
2004 |
2018 |
Left-Sided Heart Failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
110
|
4
|
0.300 |
None |
1.000 |
5 |
|
2004 |
2018 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
254
|
|
0.400 |
None |
1.000 |
5 |
|
2002 |
2020 |